Evaluation of CPB devices relative to their capabilities of reducing the transmition of gaseous microemboli (GME) to a patient during cardiopulmonary bypass
Recommends acceptable methodology for conducting gaseous microemboli (GME) testingand discusses limitations of current test methods. Tests described in this document are limited to those conducted using an in vitro circulatory system.